Experienced in Beryllium Disease

Dr. Robert P. Baughman

Pulmonary Medicine | Intensive Care Medicine
222 Piedmont Ave, 
Cincinnati, OH 
Accepting New Patients
Experienced in Beryllium Disease
222 Piedmont Ave, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robert Baughman is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Cincinnati, Ohio. Dr. Baughman is rated as an Experienced provider by MediFind in the treatment of Beryllium Disease. His top areas of expertise are Sarcoidosis, Acute Interstitial Pneumonia, Neurosarcoidosis, Endoscopy, and Lung Transplant. Dr. Baughman is currently accepting new patients.

His clinical research consists of co-authoring 221 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Beryllium Disease.

Specialties
Pulmonary Medicine
Intensive Care Medicine
Licenses
Internal Medicine in OH
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

222 Piedmont Ave, Cincinnati, OH 45219

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized Screening Trial for Cardiac Sarcoidosis (CS) in Patients Seen During Routine Clinical Care Who Have Not Been Clinically Suspected to Have (CS), Comparing the Addition of Echocardiogram and Ambulatory ECG to Standard of Care.
A Randomized Screening Trial for Cardiac Sarcoidosis (CS) in Patients Seen During Routine Clinical Care Who Have Not Been Clinically Suspected to Have (CS), Comparing the Addition of Echocardiogram and Ambulatory ECG to Standard of Care.
Enrollment Status: Completed
Publish Date: January 14, 2025
Intervention Type: Diagnostic test
A Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of Intravenous ATYR1923 in Patients With Pulmonary Sarcoidosis
A Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of Intravenous ATYR1923 in Patients With Pulmonary Sarcoidosis
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Biological
Study Drug: ATYR1923
Study Phase: Phase 1/Phase 2
A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed, Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis or Sarcoidosis on Long Term Oxygen Therapy Followed by an Optional Open-Label Long Term Extension Safety Study
A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed, Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis or Sarcoidosis on Long Term Oxygen Therapy Followed by an Optional Open-Label Long Term Extension Safety Study
Enrollment Status: Completed
Publish Date: August 10, 2022
Intervention Type: Combination product
Study Drug: iNO
Study Phase: Phase 2
Investigation of the Efficacy of Antimycobacterial Therapy on Pulmonary Sarcoidosis Phase II Randomized, Double-blind, Placebo-controlled Trial
Investigation of the Efficacy of Antimycobacterial Therapy on Pulmonary Sarcoidosis Phase II Randomized, Double-blind, Placebo-controlled Trial
Enrollment Status: Completed
Publish Date: July 09, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

221 Total Publications

WASOG Clinical Trial Endpoint Task Force: Executive Summary.
WASOG Clinical Trial Endpoint Task Force: Executive Summary.
Journal: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Published: September 02, 2025
Similar Doctors
Experienced in Beryllium Disease
Dr. Mitchell C. Rashkin
Pulmonary Medicine | Intensive Care Medicine
Experienced in Beryllium Disease
Dr. Mitchell C. Rashkin
Pulmonary Medicine | Intensive Care Medicine

University Of Cincinnati Physicians Company LLC

3130 Highland Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-584-4503
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mitchell Rashkin is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Cincinnati, Ohio. Dr. Rashkin is rated as an Advanced provider by MediFind in the treatment of Beryllium Disease. His top areas of expertise are Neurosarcoidosis, Interstitial Lung Disease, Sarcoidosis, Acute Interstitial Pneumonia, and Gastrostomy. Dr. Rashkin is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Baughman's expertise for a condition
ConditionClose
View All 23 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile